Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses
NCT ID: NCT01100411
Last Updated: 2012-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
35 participants
INTERVENTIONAL
2010-03-31
2010-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Air Optix Aqua
Contact lens material: Lotrafilcon A
Air Optix Aqua
Contact lens material: Lotrafilcon A
Biofinity
Contact lens material: Comfilcon A
Biofinity
Contact lens material: Comfilcon A
Proclear
Contact lens material: Omafilcon A
Proclear
Contact lens material: Omafilcon A
Acuvue Oasys
Contact lens material: Senofilcon A
Acuvue Oasys
Contact lens material: Senofilcon A
Acuvue 2
Contact lens material: Etafilcon A
Acuvue 2
Contact lens material: Etafilcon A
Purevision
Contact lens material: Balafilcon A
Purevision
Contact lens material: Balafilcon A
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Air Optix Aqua
Contact lens material: Lotrafilcon A
Biofinity
Contact lens material: Comfilcon A
Proclear
Contact lens material: Omafilcon A
Acuvue Oasys
Contact lens material: Senofilcon A
Acuvue 2
Contact lens material: Etafilcon A
Purevision
Contact lens material: Balafilcon A
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years old;
* Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
* Have ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses;
* Has vision correctable to at least 6/12 (20/40) or better at distance in each eye with contact lenses;
* Be experienced at wearing contact lenses.
Exclusion Criteria
* Any systemic disease that adversely affects ocular health
* An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
* Use of any topical ocular medication during trial with the exception of saline drops ;
* Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance
* Eye surgery within 12 weeks immediately prior to enrolment for this trial;
* Previous corneal refractive surgery;
* Contraindications to contact lens wear;
* Participated or currently enrolled in another clinical trial that may have affected vision or ocular physiology within the previous 2 weeks;
* Be pregnant (formal testing of pregnancy is not required. A participant's verbal report is sufficient);
* Worn soft contact lenses 2 calendar days or rigid gas permeable/ orthokeratology lenses 7 calendar days prior.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alcon Call Center
Role: STUDY_CHAIR
Alcon Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institute for Eye Research
Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M-10-01
Identifier Type: -
Identifier Source: org_study_id